Origent in the Media
Origent Featured on the “Connecting ALS” Podcast Hosted by Jeremy Holden and Produced by the ALS Association
On January 20, 2022, Dr. Dave Ennist, CEO of Origent Data sciences, was featured on an episode of the Connecting ALS podcast.
Origent Awarded Patent for its Drug Rescue DEC Analysis
On October 5, 2021, Origent Data Sciences, Inc. was awarded by the USPTO patent number 11,139,051, titled Systems and Methods for Designing Clinical Trials.
Origent, Biogen and Cytokinetics Present at AAN
Origent Chief Science Officer Dr. Dave Ennist joined representatives from Cytokinetics and Biogen on a panel at the annual conference of the American Academy of Neurology in Vancouver, BC.
Beneficial Stats – The Scientist Magazine
Origent and Sentrana scientist Dr. Liuxia Wang discusses her original work predicting disease progression for individual ALS patients.
Paper featuring Origent’s ALS Work is Designated Editor’s Choice by Science Translational Medicine
SCIENCE Translational Medicine features work by Origent’s scientists.
Crowdsourcing Project Predicts Progression of Neurodegenerative Disease
This article featuring Origent was published in SCIENCE magazine on November 4, 2014.